Cargando…
Evaluating the Role of Antibiotics in Patients Admitted to Hospital With Decompensated Cirrhosis: Lessons From the ATTIRE Trial
Hospital-acquired infections (HAI) are common in cirrhosis with antibiotics frequently used to prevent infections, but their efficacy for this role is unknown. To investigate this, we used Albumin to Prevent Infection in Chronic Liver Failure (ATTIRE) data to evaluate whether antibiotic use in patie...
Autores principales: | Kutmutia, Rishen, Tittanegro, Thais, China, Louise, Forrest, Ewan, Kallis, Yiannis, Ryder, Stephen D., Wright, Gavin, Freemantle, Nick, O'Brien, Alastair |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810015/ https://www.ncbi.nlm.nih.gov/pubmed/35970815 http://dx.doi.org/10.14309/ajg.0000000000001937 |
Ejemplares similares
-
Use of non-selective B-blockers is safe in hospitalised decompensated cirrhosis patients and exerts a potential anti-inflammatory effect: Data from the ATTIRE trial
por: Tittanegro, Thais, et al.
Publicado: (2022) -
Targeted Albumin Infusions Do Not Improve Systemic Inflammation or Cardiovascular Function in Decompensated Cirrhosis
por: China, Louise, et al.
Publicado: (2022) -
Monocyte dysfunction in decompensated cirrhosis is mediated by the prostaglandin E2-EP4 pathway
por: Maini, Alexander A., et al.
Publicado: (2021) -
Parenclitic Network Mapping Identifies Response to Targeted Albumin Therapy in Patients Hospitalized With Decompensated Cirrhosis
por: Oyelade, Tope, et al.
Publicado: (2023) -
Antimicrobial prophylaxis in decompensated cirrhosis: friend or foe?
por: Crocombe, Dominic, et al.
Publicado: (2023)